Three Georgia Tech interdisciplinary engineering student teams were among the four declared winners in their category at the MIT COVID-19 Challenge event held April 3-5. The online, virtual hackathon event attracted 1,500 people, creating 240 teams, which competed for monetary prizes, computing resources, organizational support, and direct access to key partners to further develop, validate and implement solutions developed. The 2020 MIT COVID-19 Challenge attracted more than 50 partnering organizations.
Teams could participate in one of 10 Covid-19 healthcare-related tracks. Judges selected the “final four” winners for each of the ten tracks to receive prize money and support for their presentations and ideas.
The three winning Georgia Tech teams were:
Medlynk, a five-person Georgia Tech team, won for their tracking model focused at the county level that pulls from multiple live data sources to allow hospitals to predict their personal protected equipment (PPE) burn rate, and identifies hospitals in critical need to help suppliers prioritize hospitals needs and more appropriately direct their supplies of PPE equipment.
The Medlynk team won in the Hospital Assets Coordination, and Distribution category.
The winning members of the team included: Mike Adamo (BME), Brandon D’arienzo (ME), Maximilian Hollister (BME), Sebastian Hollister (CS), and Akash Moozhayil (ME).
PopTracker, a seven-person team with six Georgia Tech students, won for designing a low-cost mesh network system of devices to report population densities in public transport by polling train cars for Wi-Fi signals from devices, which then sends the information to a web application's database for analysis, visualization and public use. Public transit users can then go online to see live data for where they should go for the least crowded train possible to maintain social distancing.
The popTracker team won in the Impact of Social Distancing and Quarantine category.
The winning members of the team included: Thomas Beckler (BME), Ricardo Meizoso (ME), Nick Mirchandani (ID), Leo Ricci (CS), Davis White (BME), Jaime Vera (BME), and Olivia Khan (co-founder, Generous Labs in Germany).
ReRoute, a six-person Georgia Tech team, won for reducing the chance of COVID-19 transmission within a hospital setting. The team developed a new term called “clinical distancing.” In order to do this, their solution called reRoute, is implemented by scanning passive RFID tags already worn by staff and patients to track personnel flow within the hospital. The tags carry a unique COVID-19 risk factor, generated by analyzing intrinsic and extrinsic health risks with which the users have interacted. Their algorithm then determines the optimal path for moving patients along the relevant hallways and in testing rooms while interfacing with local sensors to redirect traffic and notify custodial units when and where sanitization is needed.
The reRoute team won in the COVID-19 Treatment and Management category.
The winning members of the team included: Manshi Baskaran (BME), Srujani Das (BME), Saisamhitha (Sam) Dasari (BME), Prahlad Iyengar (EE), Sambhav Jain (BME), and Ruturaj Patil (ME).
Media Contact:
Walter Rich
Communications Manager
Wallace H. Coulter Department of Biomedical Engineering
Georgia Institute of Technology
Media Contact
Walter Rich
Keywords
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients